Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randal L Von Seggern

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
American Journal of Therapeutics|September 22, 2006
Using patient-centered endpoints to determine the cost-effectiveness of triptans for acute migraine therapyLeslie Kelman, Randal L Von Seggern
Headache|February 6, 2004
Rofecoxib in the prevention of perimenstrual migraine: an open-label pilot trialRandal L Von Seggern, Lisa K Mannix, James U Adelman
Headache|October 23, 2002
Efficacy of topiramate in migraine prophylaxis: a retrospective chart analysisRandal L Von Seggern, Lisa K Mannix, James U Adelman
Headache|November 18, 2004
Pharmacoeconomics: the cost of prophylactic migraine treatmentsLeon C Adelman, James U Adelman, Marshall C Freeman, et al.
Headache|February 26, 2004
Laboratory monitoring of OxyContin (oxycodone): clinical pitfallsRandal L Von Seggern, Charles P Fitzgerald, Leon C Adelman, et al.
Headache|March 12, 2004
Cost considerations of acute migraine treatmentJames U Adelman, Leon C Adelman, Marshall C Freeman, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
American Journal of Therapeutics|September 22, 2006
Using patient-centered endpoints to determine the cost-effectiveness of triptans for acute migraine therapyLeslie Kelman, Randal L Von Seggern
Headache|February 6, 2004
Rofecoxib in the prevention of perimenstrual migraine: an open-label pilot trialRandal L Von Seggern, Lisa K Mannix, James U Adelman
Headache|October 23, 2002
Efficacy of topiramate in migraine prophylaxis: a retrospective chart analysisRandal L Von Seggern, Lisa K Mannix, James U Adelman
Headache|November 18, 2004
Pharmacoeconomics: the cost of prophylactic migraine treatmentsLeon C Adelman, James U Adelman, Marshall C Freeman, et al.
Headache|February 26, 2004
Laboratory monitoring of OxyContin (oxycodone): clinical pitfallsRandal L Von Seggern, Charles P Fitzgerald, Leon C Adelman, et al.
Headache|March 12, 2004
Cost considerations of acute migraine treatmentJames U Adelman, Leon C Adelman, Marshall C Freeman, et al.
Pageof 1